After more than 20 years operating in Bloomington, the North American arm of a major Danish hearing aid manufacturer is ...

GN in 2025 will double its space in the Twin Cities by moving from Bloomington to the Shakopee building once occupied by ...

Granite Telecommunications today celebrated the grand opening of its new state-of-the-art headquarters, marking a significant ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

It was one of those conversations you never forget. We were discussing – of all things – the Covid injections, and I was questioning the early ‘safe and effective’ claims put forward by the pharmaceut ...

In the 24th year of the competition, Istanbul will stage its first-ever UEFA Women's Champions League tie this week as ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced the appointment of Deirdre P. Connelly to its Board of Directors. Ms. Connelly is a ...

Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.

During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year.